Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 3,093 | 2,572 | 1,943 | 2,461 | 2,095 |
| Operating Income | -3,093 | -2,572 | -1,943 | -2,461 | -2,095 |
| Other Income | 83 | 61 | 36 | 17 | 44 |
| Pre-tax Income | -3,009 | -2,511 | -1,907 | -2,444 | -2,051 |
| Net Income Continuous | -3,009 | -2,511 | -1,907 | -2,444 | -2,051 |
| Net Income | $-3,009 | $-2,511 | $-1,907 | $-2,444 | $-2,051 |
| EPS Basic Total Ops | -2.71 | 36.51 | -7.08 | -28.04 | -25.34 |
| EPS Basic Continuous Ops | -0.94 | 26.03 | -2.88 | -12.18 | -25.32 |
| EPS Diluted Total Ops | -2.71 | 36.51 | -7.08 | -28.04 | -25.34 |
| EPS Diluted Continuous Ops | -0.94 | 26.03 | -2.88 | -12.18 | -25.32 |
| EPS Diluted Before Non-Recurring Items | -2.71 | -1.65 | -7.08 | -28.04 | -25.32 |
| EBITDA(a) | $-3,085 | $-2,566 | $-1,936 | $-2,454 | $-2,088 |